BIT 6.82% 2.4¢ biotron limited

Ann: Significant Immunological Outcomes in BIT225 HIV-1 Trial, page-77

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,621 Posts.
    lightbulb Created with Sketch. 967
    litlecorn , Thailand trials , last hep c trial only one exited and was for completely personal reasons not the drug , we had 85 % success rate , had this one woman not leave we could have said the CURE word again .
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.